Herpesvirus telomerase RNA (vTR) with a mutated template sequence abrogates herpesvirus-induced lymphomagenesis

PLoS Pathogens

Volumn 7, Issue 10, 2011, Pages

  Kaufer, Benedikt B ^a,b   Arndt, Sina ^a   Trapp, Sascha ^a,c   Osterrieder, Nikolaus ^a,b   Jarosinski, Keith W ^a  

^a Department of Obstetrics Gynecology   (United States)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c UR1282   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERASE RNA; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; GENE MUTATION; HERPES VIRUS; IN VITRO STUDY; IN VIVO STUDY; LYMPHOMA; LYMPHOMAGENESIS; MUTAGENESIS; NONHUMAN; PROTEIN RNA BINDING; VACCINATION; VIRUS RECOMBINANT; VIRUS REPLICATION; ANIMAL; ANIMAL DISEASE; CELL TRANSFORMATION; CHICKEN; DNA TEMPLATE; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; MARDIVIRUS; MAREK DISEASE; METABOLISM; MUTATION; PATHOGENICITY; T CELL LYMPHOMA; VIROLOGY;

AVES; GALLID HERPESVIRUS 2; GALLUS GALLUS; HERPESVIRIDAE;

ANIMALS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHICKENS; GENE EXPRESSION REGULATION, LEUKEMIC; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 2, GALLID; HOST-PATHOGEN INTERACTIONS; LYMPHOMA, T-CELL; MAREK DISEASE; MUTATION; RNA; RNA, VIRAL; TELOMERASE; TEMPLATES, GENETIC; VACCINATION;

EID: 80055086269     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002333     Document Type: Article

References (44)

1. Blackburn EH, (2005) Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett 579: 859-862.
2. Blackburn EH, (2005) Telomerase and Cancer: Kirk A. Landon-AACR prize for basic cancer research lecture. Mol Cancer Res 3: 477-482.
3. Greider CW, Blackburn EH, (1987) The telomere terminal transferase of tetrahymena is a ribonucleoprotein Enzyme with 2 kinds of primer specificity. Cell 51: 887-898.
4. Chen JL, Blasco MA, Greider CW, (2000) Secondary structure of vertebrate telomerase RNA. Cell 100: 503-514.
5. Chen JL, Greider CW, (2004) Telomerase RNA structure and function: implications for dyskeratosis congenita. Trends Biochem Sci 29: 183-192.
6. Mitchell JR, Cheng J, Collins K, (1999) A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3′ end. Mol Cell Biol 19: 567-576.
7. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, et al. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015.
8. Shay JW, Bacchetti S, (1997) A survey of telomerase activity in human cancer. Eur JCancer 33: 787-791.
9. Bellon M, Nicot C, (2008) Regulation of telomerase and telomeres: Human tumor viruses take control. J Natl Cancer Inst 100: 98-108.
10. Horikawa I, Barrett JC, (2003) Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 24: 1167-1176.
11. Liu H, Luan F, Ju Y, Shen HY, Gao LF, et al. (2007) In vitro transfection of the hepatitis B virus PreS2 gene into the human hepatocarcinoma cell line HepG2 induces upregulation of human telomerase reverse transcriptase. Biochem Biophys Res Commun 355: 379-384.
12. Zhu ZW, Wilson AT, Gopalakrishna K, Brown KE, Luxon BA, et al. (2010) Hepatitis C virus core protein enhances telomerase activity in Huh7 cells. J Med Virol 82: 239-248.
13. Zhu ZW, Wilson AT, Gopalakrishna KN, Brown K, Luxon BA, et al. (2008) Hepatitis C virus core protein upregulates telomerase activity in hepatoma cells. Hepatology 48: 974A-974A.
14. Calnek BW, (2001) Pathogenesis of Marek's disease virus infection. In: Hirai K, editors. Marek's disease Berlin, Germany Springer pp. 25-55.
15. Osterrieder N, Kamil JP, Schumacher D, Tischer BK, Trapp S, (2006) Marek's disease virus: from miasma to model. Nat Rev Microbiol 4: 283-294.
16. Brown AC, Baigent SJ, Smith LP, Chattoo JP, Petherbridge LJ, et al. (2006) Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek's disease virus. Proc Natl Acad Sci U S A 103: 1687-1692.
17. Brown AC, Smith LP, Kgosana L, Baigent SJ, Nair V, et al. (2009) Homodimerization of the Meq viral oncoprotein is necessary for induction of T-cell lymphoma by Marek's disease virus. J Virol 83: 11142-11151.
18. Jarosinski KW, Tischer BK, Trapp S, Osterrieder N, (2006) Marek's disease virus: lytic replication, oncogenesis and control. Expert Rev Vaccines 5: 761-772.
19. Fragnet L, Blasco MA, Klapper W, Rasschaert D, (2003) The RNA subunit of telomerase is encoded by Marek's disease virus. J Virol 77: 5985-5996.
20. Fragnet L, Kut E, Rasschaert D, (2005) Comparative functional study of the viral telomerase RNA based on natural mutations. J Biol Chem 280: 23502-23515.
21. Trapp S, Parcells MS, Kamil JP, Schumacher D, Tischer BK, et al. (2006) A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis. J Exp Med 203: 1307-1317.
22. Kaufer BB, Trapp S, Jarosinski KW, Osterrieder N, (2010) Herpesvirus telomerase RNA(vTR)-dependent lymphoma formation does not require interaction of vTR with telomerase reverse transcriptase (TERT). PloS Pathog 6: e1001073.
23. Kim MM, Rivera MA, Botchkina IL, Shalaby R, Thor AD, et al. (2001) A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation. Proc Natl Acad Sci U S A 98: 7982-7987.
24. Lin J, Smith DL, Blackburn EH, (2004) Mutant telomere sequences lead to impaired chromosome separation and a unique checkpoint response. Mol Biol Cell 15: 1623-1634.
25. Djojosubroto MW, Chin AC, Go N, Schaetzlein S, Manns MP, et al. (2005) Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma. Hepatology 42: 1127-1136.
26. Gellert GC, Dikmen ZG, Wright WE, Gryaznov S, Shay JW, (2006) Effects of a novel telomerase inhibitor, GRN163L, in human breast cancer. Breast Cancer Res Treat 96: 73-81.
27. Himly M, Foster DN, Bottoli I, Iacovoni JS, Vogt PK, (1998) The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses. Virology 248: 295-304.
28. Moscovici C, Moscovici MG, Jimenez H, Lai MMC, Hayman MJ, et al. (1977) Continuous tissue-culture cell lines derived from chemically-induced tumors of Japanese quail. Cell 11: 95-103.
29. Li XH, Jarosinski KW, Schat KA, (2006) Expression of Marek's disease virus phosphorylated polypeptide pp38 produces splice variants and enhances metabolic activity. Vet Microbiol 117: 154-168.
30. Jarosinski KW, Margulis NG, Kamil JP, Spatz SJ, Nair VK, et al. (2007) Horizontal transmission of Marek's disease virus requires U S2, the UL13 protein kinase, and gC J Virol 81: 10575-10587.
31. Tischer BK, von Einem J, Kaufer B, Osterrieder N, (2006) Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. BioTechniques 40: 191-197.
32. Schat KA, Calnek BW, Fabricant J, (1982) Characterization of two highly oncogenic strains of Marek's disease virus. Avian Pathol 11: 593-605.
33. Yamaguchi T, Kaplan SL, Wakenell P, Schat KA, (2000) Transactivation of latent Marek's disease herpesvirus genes in QT35, a quail fibroblast cell line, by herpesvirus of turkeys. J Virol 74: 10176-10186.
34. Witter RL, Kreager KS, (2004) Serotype 1 viruses modified by backpassage or insertional mutagenesis: approaching the threshold of vaccine efficacy in Marek's disease. Avian Dis 48: 768-782.
35. Lee LF, Lupiani B, Silva RF, Kung HJ, Reddy SM, (2008) Recombinant Marek's disease virus (MDV) lacking the Meq oncogene confers protection against challenge with a very virulent plus strain of MDV. Vaccine 26: 1887-1892.
36. Katneni U, Schmidt C, Keeler C, Golovan S, Reddy S, et al. Analysis of immune signaling in Marek's disease virus vaccinated chickens. In: Spatz S, Moody A, editors. The 5 th International Workshop on the Molecular Pathogenesis of Marek's Disease Virus and 1 st Symposium on Avian Herpesviruses 2010; Athens, GA United States Department of Agriculture, Agriculture Research Service pp. 47-47.
37. Gimeno IM, (2008) Marek's disease vaccines: A solution for today but a worry for tomorrow? Vaccine 26: C31-C41.
38. Wozniakowski G, Samorek-Salamonowicz E, Kozdrun W, (2011) Molecular characteristics of Polish field strains of Marek's disease herpesvirus isolated from vaccinated chickens. Acta Vet Scand 53: 10.
39. Schat KA, Sellers HS, (2008) Cell-culture methods. In: Dufour-Zavala L, Swayne DE, Glisson JR, Pearson JE, Reed WM, editors. A laboratory manual for the identification and characterization of avian pathogens: American Association of Avian Pathologists, Jacksonville, FL pp. 195-203.
40. Schumacher D, Tischer BK, Fuchs W, Osterrieder N, (2000) Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. J Virol 74: 11088-11098.
41. Jarosinski KW, Osterrieder N, Nair VK, Schat KA, (2005) Attenuation of Marek's disease virus by deletion of open reading frame RLORF4 but not RLORF5a. J Virol 79: 11647-11659.
42. Jarosinski KW, O'Connell PH, Schat KA, (2003) Impact of deletions within the Bam HI-L fragment of attenuated Marek's disease virus on vIL-8 expression and the newly identified transcript of open reading frame LORF4. Virus Genes 26: 255-269.
43. Chbab N, Egerer A, Veiga I, Jarosinski KW, Osterrieder N, (2010) Viral control of vTR expression is critical for efficient formation and dissemination of lymphoma induced by Marek's disease virus (MDV). Vet Res 41.
44. Piepenbrink MS, Li XH, O'Connell PH, Schat KA, (2009) Marek's disease virus phosphorylated polypeptide pp38 alters transcription rates of mitochondrial electron transport and oxidative phosphorylation genes. Virus Genes 39: 102-112.